Proove Bioscience

Discussion in 'Proove Biosciences' started by Anonymous, Sep 16, 2013 at 11:12 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

     

  2. anonymous

    anonymous Guest

    Your a idiot
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

     
  5. anonymous

    anonymous Guest

    *you’re
     
  6. anonymous

    anonymous Guest

    Hi Joe, still can’t spell and stilll have horrible grammar. Probably still stealing from folks.... Some things don’t change.
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

    Case is still open!!! Brian is in big trouble. He’s a con man and Joe needs to go to school an get an education. Your grammar gives you away, Joe.
     
  10. anonymous

    anonymous Guest

     
  11. anonymous

    anonymous Guest

     
  12. anonymous

    anonymous Guest

    Welp, since Proove has been shutdown for a while what has everyone been up to? Hopefully everyone has found new jobs.
     
  13. anonymous

    anonymous Guest

    enjoying life and looking forward to Brian’s consequences from his Proove scam. Happy New Year
     
  14. anonymous

    anonymous Guest

    Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

    In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
     
  15. anonymous

    anonymous Guest

     
  16. anonymous

    anonymous Guest

    Tt
     
  17. anonymous

    anonymous Guest

    HR insider here...I concur...nothing but sunshine and lollipops from here to er’, uh’, mmmm...oh never mind.......let’s just call it a “bump” in the road...
     
  18. anonymous

    anonymous Guest

     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest

    I